FDA submission expected in second half of Q3 and a possible decision in Q4 but IMO its most likely Q1 27. Could be a bumpy ride for the SP for a few months. The future of the company is dependent on the FDA approval for CIC.
RE: Analysts meeting 8 June - current target 7.5 pence31 May 2026 22:38
Only managed to find an interview from Nov 25.
I have messaged MW but on previous occasions he hasnβt replied so not sure he will now. Full year result due soon so I hope we will learn more then if not before.
RE: Analysts meeting 8 June - current target 7.5 pence29 May 2026 18:04
They donβt have to rns it and I hope they have submitted but I would have expected an update on it. I need to listen to the recent interview(s) and see if anything was said.
After years of holding at a big loss I decided to sell whatever little was left. My source on the ground tells me the Chinese are moulding bricks and selling them to the locals. I would not treat the info as gospel but it was enough for me to call it a day with this. GLA
I have followed and invested in GENI for a few years now. 'They will just drop FDA approval RNS' is very misleading. The company has a bright future but FDA approval can take several months.